Tag Archives: Orphan Drugs

Right From The Beginning: Returning To The Origins Of The Orphan Drug Movement
May 1, 2018

This blog was co-written by Doug Kerr, Head of Preclinical Research & Clinical Development, and Geoff McDonough, CEO, both of GenerationBio, as part of the From The Trenches feature of LifeSciVC. Our industry stands at the beginning of the most

Leave a comment